Logan Stone Capital’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-197,941
Closed -$1.94M 179
2022
Q2
$1.94M Sell
197,941
-9,860
-5% -$96.6K 1.42% 13
2022
Q1
$2.03M Buy
+207,801
New +$2.02M 1.46% 13

Other funds holding MSAC

Logan Stone Capital's MSAC Position: Q3 2022 in Review

Logan Stone Capital sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q3 2022, closing a stake of 197,941 shares — an estimated $1.94M sold.

Logan Stone Capital first reported a position in MSAC in Q1 2022 and held it in 2 quarters. The position peaked at $2.03M in Q1 2022. 53 funds tracked by Wall St. Rank hold MSAC as of Q3 2022.

  • Logan Stone Capital reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q3 2022 after selling out during the quarter.
  • Logan Stone Capital sold 197,941 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q3 2022, an estimated $1.94M.
  • Logan Stone Capital first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q1 2022 and held it in 2 quarters.
  • Logan Stone Capital's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $2.03M in Q1 2022.
  • 53 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q3 2022.

Based on Logan Stone Capital's 13F filing for Q3 2022, filed 14 Nov 2022.